David Hendren

Most people in venture capital are content to admire a technology from across a conference table. David Hendren went and built one. As Chief Business Officer of QURA, Inc., he sits at the commercial center of a preclinical medical technology company with an unusually literal ambition: put a sensor inside a person and let it report back.

QURA's platform is an implantable biosensor that captures medical-grade blood-pressure waveform data and transmits it wirelessly, in real time, to both patient and physician. The pitch is not gadgetry for its own sake. Hypertension is managed today with intermittent snapshots - a cuff at a clinic, a reading at home, long gaps in between. QURA's wager is that continuous truth beats the occasional guess, and that better data lowers both clinical risk and cost.

That is the kind of bet Hendren has spent a career learning how to make. He describes his work plainly: launching, financing and building ventures from incubation to exit. At QURA the job is everything that turns a clever implant into a real business - strategy, partnerships, capital, and the long campaign of getting medical technology from the bench toward the clinic.

He does it from Massachusetts, with the company rooted in Duxbury and Hendren himself working out of the Boston area. The team is small and deliberate. The technology partner is Helbling Technik in Bern, Switzerland - the kind of precision-engineering shop you hire when the product has to survive inside a human being. The advisory board reads like a who's-who of medical innovation, including a former Cleveland Clinic CEO and a co-founder of Intuitive Surgical.

The easy way to describe David Hendren is by his title, and the title undersells him. Chief Business Officer sounds like a single lane. His career is a roundabout. He has been the person deciding whether to fund a company and the person sweating whether their company will get funded - sometimes within the same decade, occasionally within the same week.

There is a quiet irony in a lawyer spending his days on implantable hardware. The JD suggests caution, paper, the careful no. The work demands the opposite: conviction in physical products that have to survive surgery, regulation and the long road through preclinical development. He seems to enjoy holding both - the discipline of counsel and the appetite of a founder.

He also keeps showing up in the unglamorous seats. Grant review boards. Accelerator mentorship. Advisory roles that pay in influence rather than headlines. These are the rooms where early companies live or die, and they tend to attract people who care more about the ecosystem than the spotlight.

And then there is the detail that makes the story human: QURA's CEO is William G. Hendren, MD. Two Hendrens, one company, one implant - a venture that is as much a partnership as a pitch deck. Whatever else QURA is, it is personal.